This program is part of a series of Topics in Neurology programs; Click Here for information.
Parkinson's disease (PD) is a fairly common neurodegenerative disease, affecting 3% of older adults. The cardinal motor symptoms of PD, upon which the clinical diagnosis depends, include bradykinesia, resting tremor, rigidity, and postural instability. These symptoms are primarily the result of the degeneration of the dopamine-producing cells in the substantia nigra.
However, a wide range of both motor and non-motor symptoms, as well as extensive research, demonstrate the involvement of other neurotransmitters, including the glutamatergic, serotonergic, adenosine, adrenergic, and cholinergic pathways. This, in turn, has led to the research and use of a wide variety of medications to treat these symptoms, making the comprehensive management of PD increasingly complex.
With no known cure for PD, current therapy focuses on trying to improve both motor and non-motor symptoms and to prevent further neurological damage. This program will provide clinicians with a better understanding of the mechanisms leading to the development of PD, as well as an improved ability to manage both the motor and non-motor symptoms of PD.
This activity is intended for community neurologists, PD specialists, and other health care professionals who manage patients with PD.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Develop individualized therapies that optimize motor function while minimizing the impact of dyskinesias
- Formulate treatment plans to manage the adverse effects associated with PD therapy
- Incorporate the management of non-motor symptoms into the individualized care of patients with PD
Speaking Faculty / Steering Committee
Cheryl Waters, MD, FRCP(C)
Albert B. and Judith L. Glickman
Professor of Neurology
Columbia University Medical Center
New York, NY
Cheryl Waters, MD, FRCP(C) is the Albert B. and Judith L. Glickman Professor in the Division of Movement Disorders at Columbia University. She has been involved in research on the genetics of Parkinson's disease and the treatment of this disorder. Dr. Waters has been an investigator in numerous studies involving a variety of new medical and surgical treatments. She has authored numerous articles and book chapters, as well as one book in its seventh edition.
Yvette Bordelon, MD, PhD
Associate Clinical Professor
Department of Neurology
David Geffen School of Medicine at UCLA
Los Angeles, CA
Yvette Bordelon, MD, PhD received her medical doctorate and PhD degrees from the University of Pennsylvania School of Medicine in Philadelphia. Her graduate work with Dr. Marie-Francoise Chesselet elucidated pathophysiological mechanisms occurring soon after excitotoxin injury in the intrastriatal quinolinic acid injection rat model of Huntington disease. She went on to perform residency training in neurology at Massachusetts General and Brigham and Women's Hospitals, where she served as Chief Resident in her final year. She then performed a Movement Disorders Fellowship at Columbia University.
Dr. Bordelon joined the faculty of the UCLA Neurology Department in 2004 in the Movement Disorders Program. Her clinical practice focuses on the treatment of Parkinson's disease, atypical Parkinsonian disorders, Huntington disease, and other movement disorders. Dr. Bordelon's clinical research interests include development of biomarkers in neurodegenerative diseases and the conduct of clinical trials in PD and other movement disorders.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category I Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit or the evaluation, please email email@example.com.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program sponsored by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
Method of Participation
To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. A CME certificate will be provided upon submission of a completed evaluation form.
There is no fee associated with this program.
Event staff will be glad to assist you with any special needs. Please email firstname.lastname@example.org at least 5 days prior to the program.
Jointly PROVIDED By
|Jointly provided by Potomac Center for Medical Education and Rockpointe
This educational activity has been supported through an independent educational grant from Teva Pharmaceuticals.
By clicking the Registration Button below you are agreeing that you have read and understood the CME/CE Statements above.
Registration is for planning purposes only. Seating is limited and will be provided on a first-come, first-served basis.